baber/WOPTO huggingface dataset:
Patent NZ-335900-A (NZ)
Title: A stator for a rotating electric machine and a method of manufacturing a stator
Inventor: LARSSON BERTIL
IPC: H01F5/06
Filed: 1997-11-04
Abstract: The present specification relates to a stator for a rotating electric machine, comprising a stator, with a stator core and a winding, and a rotor.  The stator core is provided with stator teeth (3) extending radially inwards, towards the rotor.   Each stator tooth (3) is configured as a number of tooth sections (7) joined axially into a stator tooth plank (2) and a number of stator tooth planks are fitted together side by side thus forming a section (1A, 1B, 1C, 1D) of a stator core or a complete stator core.  Also provided is a corresponding method for use in the manufacturing of a stator, and a rotating electric machine including such a stator.
Patent NZ-336157-A (NZ)
Title: Heterocyclic carboxylic acid derivatives and use thereof as endothelin receptor antagonists
Inventor: AMBERG WILHELM
IPC: C07D403/12
Filed: 1997-12-04
Abstract: Carboxylic acid derivatives of formula I, wherein  R1, R2, R3, R4 and R5 are as described in the specification,  X is nitrogen or methane; with the proviso that if x = nitrogen then z = nitrogen and if x = methane then at least one of the ring members Y or Z is nitrogen.  Y is nitrogen or CR9  Z is nitrogen or CR10  R9 and R10 (which can be identical or different) are: hydrogen, hydroxyl, NH2, NH(C1-C4-alkyl), N(C1-C4-alkyl)2, halogen, C1-C4-alkyoxy, C1-C4-haloalkoxy or C1-C4-alkylthio; C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl; or CR9 or CR10 is linked with CR2 as indicated above to give a 5 or 6 membered ring.  W is sulfur, oxygen or a single bond  Q is oxygen or nitrogen, with the proviso that if Q = nitrogen then W is a singe bond.  Also disclosed is the use of formula one as an endothelin receptor antagonist and its use in the treatment of illnesses in which raised endothelin levels occur.  Such illnesses include the treatment of cardiac insufficiency, restenosis, high blood pressure, acute/chronic kidney failure and prostate cancer.
Patent NZ-337189-A (NZ)
Title: method of extracting a fat soluble compound from anaqueous solution using a fluidized bed of crystalline metallic ore particles
Inventor: KEATING PETER JAMES
IPC: B01J8/20
Filed: 1999-08-09
Abstract: A method of extracting fat-soluble compounds such as a b carotene from aqueous solutions comprises: a) applying an aqueous solution containing a fat soluble compound to near the bottom of a bed of crystalline metallic ore particles held in an appropriate vessel at a rate sufficient to form and maintain a fluidized bed of crystalline metallic ore particles; b) allowing the fat soluble compound to attach to the crystalline metallic ore particles to form a crystalline metallic ore fat soluble compound complex; c) washing the complex of step b) with a wash solution to desorb the fat soluble compound from the complex; d) collecting  the wash solution containing the fat soluble compound and isolating the compound from the wash solution.
Patent NZ-502501-A (NZ)
Title: Push-on bottle closure
Inventor: DRUITT RODNEY MALCOLM
IPC: B65D41/47
Filed: 1998-07-03
Abstract: Provided is a push-on closure (10) that can be pushed on to a container (12) and then screwed off. The container (12) has a neck (11) that is provided with a multi-start thread comprising alternating ridges (25) and grooves (26). The closure (10) includes a substantially circular top (13) and a depending skirt (14) with the skirt having a number of lugs (21) that are spaced apart circumferentially by distances corresponding to the spacing of the grooves (26) of the thread. When the closure (10) is attached to the neck (11) of the container (12), each of the lugs (21) engages with one of the recesses (27) formed in the neck (11). A ramp member (29) is also located adjacent each recess (27) so that upon relative rotation of the closure (10) at least some of the lugs (21) will bear against at least some of the ramp members (29) and be directed by the ramp members (29) into the grooves (26) in the thread to allow the closure (10) to be unscrewed from the neck (11) of the container (12).
Patent NZ-502559-A (NZ)
Title: Wedge type golf club tri-level sole configuration
Inventor: ADAMS BYRON H
IPC: A63B53/04
Filed: 2000-01-25
Abstract: An iron type gold club head 10 includes a heel 18, toe 20, ball striking face 16, a rear surface 22 and a bottom sole 24 extending between the heel and toe.  Bottom sole 24 comprises a leading edge 32 at the interface of ball striking face 16 and bottom sole 24.  A trailing edge 36 is at the interface of rear surface 22 and bottom sole 24.  A midline extends in heel 18 to toe 20 direction on bottom sole 24.  Bottom sole 24 has a first support surface 26, a second support surface 28 and a third support surface 30.  First support surface 26 is located between leading edge 32 and the midline at a first angle with respect to ball striking face 16.  Second support surface 28 is located between the midline and trailing edge 36 at a second angle with respect to ball striking face 16.  The second angle is greater than the first angle and the third surface is located adjacent heel 18 at a third angle with respect to ball striking face 16.  The third angle is greater than the second angle.
Patent NZ-505880-A (NZ)
Title: IL-18 receptor polypeptides
Inventor: SIMS JOHN E
IPC: C07K19/00
Filed: 1999-01-22
Abstract: A polypeptide comprises at least one IL-1Rrp1 polypeptide linked to at least one AcPL polypeptide. The IL-1Rrp1 polypeptide is encoded by a DNA selected from the group consisting of: a) DNA comprising a nucleotide sequence selected from the group consisting of the coding region of the sequence presented in SEQ ID NO:3 and the coding region of the sequence presented in SEQ ID NO: 7; b) DNA that is complementary to DNA capable of hybridising to the DNA of a). The hybridisation conditions include prewashing with 5X SSC, 0.5% SDS and hybridising at 55oC and 5X SSC and c) DNA that encodes the amino acid sequence presented in SEQ ID NO:4 or that encodes the amino acid sequence presented in SEQ ID NO:8. The AcPL polypeptide is encoded by a DNA selected from the group consisting of: a') DNA comprising a nucleotide sequence selected from the group consisting of the coding region of the sequence presented in SEQ ID NO:1 and the coding region of the sequence presented in SEQ ID NO: 5; b') DNA that is complementary to DNA capable of hybridising to the DNA of a'). The hybridisation conditions include prewashing with 5X SSC, 0.5% SDS and hybridising at 55oC and 5X SSC and c') DNA that encodes the amino acid sequence presented in SEQ ID NO:2 or that encodes the amino acid sequence presented in SEQ ID NO:6.  Also described is a process for preparing the polypeptide, a pharmaceutical composition comprising the polypeptide and its use for inhibiting the effects of IL-18.
Patent NZ-513400-A (NZ)
Title: Air cleaning apparatus suitable for small diameter flues with low gas flow rates
Inventor: BEST ROGER JOHN
IPC: F23J15/04
Filed: 2001-08-07
Abstract: An air cleaning apparatus for cleaning flue gases from domestic fireplace is disclosed, which comprises a housing which is adapted to be attached to the flue and which includes: means to induce a swirl to incoming flue gases into a spray chamber within the housing; a water manifold located within the spray chamber and having a plurality of nozzles to supply water in the form of spray and/or fog to mix with the gases within the spray chamber; means to direct the mixture of water and the flue gases within the spray chamber to means to separate the water from the flue gases; means to direct the flue gases being separated from the water into a fan chamber; and a motor-driveable fan located within the fan chamber to draw the flue gases into the fan chamber and to direct the gases to an outlet.
Patent NZ-518946-A (NZ)
Title: Novel composition and use
Inventor: LILLIOTT NICOLA JAYNE
IPC: A61K31/425
Filed: 2000-11-16
Abstract: A composition of a thiazolidinedione and metformin hydrochloride, wherein each of said components is dispersed within its own (different) carrier; and a process for its preparation.
Patent NZ-521787-A (NZ)
Title: Tube scraper with bent wire in form of concatenated resilient segments connected by geinculations
Inventor: WANG DEMAO
IPC: B08B9/02
Filed: 2000-07-12
Abstract: A scraper 9 for removing deposits from the exterior of a tubular member 34 includes elements defining an outer jacket 10 which has an inwardly open circumferential recess and two aligned axial openings, and a scraper element 12 in the form of an elongate resilient wire bent to define a series of integral, concatenated, resilient segments 26, each pair of adjacent segments being connected through a bend or geniculation 28. All geniculations 28 are received within the recess, and each segment 26a of wire extends generally along a chord of the aligned axial openings. The positions of the chords are distributed around the circumference of the axial openings such that, in order for the tubular member 34 to be accommodated through the aligned openings, the various segments must be deformed outwardly, whereby the resilience of the thus deformed segment urges it inwardly against the tubular member 34, and causes it to clean the tubular member 9 as the scraper moves axially.
Patent NZ-526169-A (NZ)
Title: Oral dosage self-emulsifying formulations of pyranone protease inhibitors
Inventor: CHEN SHIRLYNN
IPC: A61K31/37
Filed: 2001-10-30
Abstract: Disclosed is a pharmaceutical composition with less than 0.5% of ethanol and/or propylene glycol, comprising: (a) a pyranone compound of formula I, (b) one or more pharmaceutically acceptable surfactants, (c) a polyethylene glycol solvent having a mean molecular weight of greater than 300 but lower than 600, and (d) a basic amine in an amount from 0.1% to 10% by weight of the total composition, wherein the basis amine is a lower alkylamine, basic amino acid or choline hydroxide. The pharmaceutical composition is used for the manufacture of medicaments for the prophylaxis or treatment of viral infections caused by retroviruses.
Patent NZ-529983-A (NZ)
Title: Sphingosine kinase interacts with TRAF2 and modulates tumor necrosis factor-induced cellular activity
Inventor: XIA PU
IPC: C12N5/09
Filed: 2002-06-03
Abstract: Disclosed is the use of an agent modulating the interaction of sphingosine kinase with a TRAF in the manufacture of a medicament for the treatment of a condition in a mammal characterised by aberrant, unwanted or otherwise inappropriate cytokine induced cellular activity. Agonists and up-regulators of the sphingosine kinase/TRAF interaction have the effect of up-regulating cellular activity while antagonists down-regulate cellular activity. Also disclosed is a method of determining agents capable of interacting with the TRAF binding site comprising contacting sphingosine kinase with a putative agent and assessing the degree of interactive complementarity of the agent with the binding site.
Patent NZ-531174-A (NZ)
Title: Process for reducing the levels of organic solvents in carbapenem compounds
Inventor: CVETOVICH RAYMOND
IPC: C07D477/20
Filed: 2002-09-20
Abstract: Disclosed is a process for reducing the levels of organic solvents in a crystalline carbapenem to pharmaceutically acceptable levels, comprising washing the crystalline carbapenem containing organic solvent with an organic solvent containing water to produce a washed carbapenem solid containing residual organic solvent; and evaporating the residual organic solvent in the washed carbapenem solid using vacuum and/or inert gas at low temperature to produce a crystalline carbapenem solid containing pharmaceutically acceptable levels of residual organic solvents, is maintained at about 13% to about 25% during the process. Also disclosed is a process for making a novel crystalline hydrate, Form C of the compound of formula IIa, comprising washing a crystalline carbapenem of Form A or Form B with an organic solvent selected from methyl acetate, acetone or a mixture thereof containing water and isolating crystalline hydrate Form C of the carbapenem solid formula IIa.
Patent NZ-537634-A (NZ)
Title: The use of an immunogenic conjugate comprising at least one VEGF peptide moiety coupled to a carrier for use in combating tumours
Inventor: GLOVER JAMES
IPC: A61K47/48
Filed: 2003-06-17
Abstract: Described is an immunogenic conjugate for combating tumours and tumour metastasis comprising at least one vascular endothelial growth factor (VEGF) peptide moiety coupled to a carrier, where the carrier is selected from the group consisting of the purified protein derivative of tuberculin, tetanus toxoid, diphtheria toxoid, keyhole limpet haemocyanin, glutathione S-transferase and derivatives thereof.
Patent NZ-539903-A (NZ)
Title: Method of stimulating hair growth using benzopyrans
Inventor: DOHERTY NIALL STEPHEN
IPC: A61P17/14
Filed: 2003-11-03
Abstract: Disclosed is the use of (3S,4R)-3,4-dihydro-4-(2,3-dihydro-2-methyl-3-oxopyridazin-6-yl)oxy-3-hydroxy-6-(3-hydroxyphenyl)sulphonyl-2,2,3-trimethyl-2H-benzo[b]pyran, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for treating an alopecia selected from the group consisting of alopecia areata, hair loss secondary to chemotherapy, or radiation treatment, stress-related hair loss, self-induced hair loss, and scarring alopecia.
Patent NZ-544002-A (NZ)
Title: Process for producing a nanoscale zero-valent metal
Inventor: FEITZ ANDREW
IPC: B22F9/24
Filed: 2004-05-26
Abstract: Disclosed is a process for producing a nanoscale zero-valent metal, including reduction of a metal ion solution with a dithionite compound, wherein the reduction is carried out under alkaline conditions under substantially an inert atmosphere. A nanoscale zero-valent metal produced by this process, and having a new crystalline form is also described. The nanoscale zero-valent metal produced by the process is preferably iron, and is advantageously used for the remediation of contaminated water.
Patent NZ-550515-A (NZ)
Title: Methods and apparatus for selecting between multiple carriers using a single receiver chain tuned to a single carrier
Inventor: LAROIA RAJIV
IPC: H04B17/00
Filed: 2004-10-15
Abstract: A communications system comprises a portable communications device and a first base station. The portable communications device includes i) a receiver antenna for receiving a signal including a first component and a second component; ii) a controllable filter coupled to the antenna for filtering the received signal and for passing signals in a selected one of a first frequency band and a second frequency band while discarding at least some frequencies included in the other one of the first and second frequency bands, iii) a first signal measurement device coupled to the controllable filter for performing a first signal measurement on the first signal component to generate a first signal quality indicator; iv) a second signal measurement device coupled to the controllable filter for performing a second signal measurement on the second signal component to generate a second signal quality indicator; v) a frequency band selection module for selecting between operating in the first frequency band and a second frequency band as a function of the first and second signal quality indicators and for generating a control signal used to control the one of the first and second frequency bands which will be passed by the controllable filer. The first and second signal components are within the selected one of the first and second frequency bands. The first signal component is associated with the first frequency band and the second signal component is associated with the second frequency bands. The base station is located in a communications cell and includes a first transmitter which primarily transmits in the first frequency band for transmitting the first signal component.
Patent NZ-550816-A (NZ)
Title: Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
Inventor: JAKOBOVITS AYA
IPC: A61K39/00
Filed: 2004-04-22
Abstract: Provided is an antibody or functional fragment thereof comprising a complementarity determining region (CDR) from an antibody designated X120.545.1.1 (ATCC Accession number PTA-5803); wherein the antibody or antibody fragment binds to the STEAP-1 protein of a specified sequence. Further provided are transgenic animals that produce the antibody and antibodies coupled to various therapeutic toxins.
Patent NZ-551406-A (NZ)
Title: Treatment of non small cell lung cancer with gemcitabine and erlotinib (an egfr kinase inhibitor)
Inventor: HIGGINS BRIAN
IPC: A61K31/498
Filed: 2005-05-27
Abstract: Disclosed is the use of erlotinib and gemcitabine for the preparation of a medicament for treating non-small-cell lung cancer (NSCLC).
Patent NZ-551870-A (NZ)
Title: Genetically engineered pyrroloquinoline quinone dependent glucose dehydrogenase comprising an amino acid insertion
Inventor: BOENITZ-DULAT MARA
Filed: 2005-07-19
Abstract: Provided is a variant of PQQ-dependent soluble glucose dehydrogenase polypeptide comprising one amino acid insertion at position 428-428 of the wild type sequence from Acinetobacter calcoaceticus. Further provided are specific variants with specified amino acids in that position, and with further amino acid insertions in other specified positions. Also provided are corresponding polynucleotides, vectors coding for the variant, cells containing the vector, methods of producing the variants. The compositions and methods are useful for determining concentrations of sugars in a sample.
Patent NZ-552284-A (NZ)
Title: Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
Inventor: HENRIKSSON MARTIN
IPC: C07D413/14
Filed: 2005-05-24
Abstract: The disclosure relates to compounds with the formula (III) wherein R5, R6, R7 are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds, as well as methods of use of the compounds for treatment of disorders associated with human hydroxysteroid dehydrogenase type 1 enzyme and for the preparation of a medicament which acts on the human 11-hydroxysteroid dehydrogenase type 1 enzyme.
Patent NZ-552760-A (NZ)
Title: Message transmission system and message transmission method
Inventor: SAWADA HISANORI
IPC: G06F21/31
Filed: 2005-06-30
Abstract: A message transmission system is provided. The system includes a registration accepting part for accepting a membership number, a subscriber telephone number, and a subscribed service ID; a subscriber information storage for storing membership numbers, subscriber telephone numbers, and subscribed service IDs in association with each other; a transmission request receiver for receiving a membership number of a message destination and a service ID of a Web server from the Web server or from communication terminal; a communication address converter for referring to the subscriber information storage on the basis of the received membership number and service ID to retrieve the subscriber telephone number corresponding to the membership number and service ID; and a message output part for outputting a predetermined message while designating the retrieved subscriber telephone number.
Patent NZ-553922-A (NZ)
Title: Ink composition for inkjet printing
Inventor: SHIOTANI TOSHIHIKO
IPC: B41J2/01
Filed: 2005-05-18
Abstract: Disclosed is an ink composition for ink-jet printing, comprising a pigment in an amount of 0.1 to 15 mass %, a binder resin in an amount of 0.5 to 15 mass %, a pigment dispersant in an amount of 0.1 to 15 mass %, and a solvent in an amount of 60 to 99 mass %, wherein the solvent is a mixture of: (1) at least one glycol ether in an amount of 15 to 95 mass % and at least one of a lactone compound in an amount of 1 to 45 mass %, (2) at least one glycol ether in an amount of 15 to 95 mass % and 2-pyrrolidone in an amount of 1 to 45 mass %, or (3) at least one glycol ether acetate in an amount of 15 to 90 mass % and isophorone in an amount of 0.5 to 30 mass %, wherein the binder resin is a vinyl chloride copolymer resin and wherein the pigment dispersant is a polyester-polyamide resin having two or more amido groups in the one molecule thereof and a number average molecular weight of 2,000 to 15,000. The ink-jet printer using this ink composition is free from nozzle clogging to thereby enable obtaining a print of desirable printing quality, and that can ensure appropriate drying rate for printing and further excels in colour development.
Patent NZ-554870-A (NZ)
Title: Process for production of (4,5-dihydroisoxazol-3-Yl)thio- carboxamidine salts
Inventor: UCHIDA YUKIO
IPC: C07B61/00
Filed: 2005-12-19
Abstract: Disclosed is a method for producing a (4,5-dihydroisoxazol-3-yl)thiocarboxamidine salt compound of the formula (2) wherein each of R1 and R2 which are independent of each other, is a hydrogen atom, an alkyl group or a cycloalkyl group, each of R3 and R4 which are independent of each other, is a hydrogen atom or an alkyl group, provided that R1 and R2, or R2 and R3, may be bonded to each other to form a cycloalkyl group together with the carbon atoms to which they are bonded, and X2 is a halogen or an anionic residue derived from an acid, which comprises reacting a 3-halogeno-4,5-dihydroisoxazole compound of the formula (1) wherein R1, R2, R3 and R4 are as defined above, and X1 is a halogen, with thiourea in the presence of an acid.
Patent NZ-554942-A (NZ)
Title: Installation of cured in place liners with air and steam to cure using a perferated hose to supply the steam
Inventor: DRIVER FRANKLIN THOMAS
IPC: F16L55/165
Filed: 2005-11-02
Abstract: A process for lining an existing pipeline (12) or conduit with a flexible resin impregnated cured in place liner (18) is disclosed. The liner (18) and a resin impregnated inflation bladder are pulled through the pipeline (12) to be repaired by a winch (43) and cable (15). The bladder is then inflated with air and the resin cured with flow-through steam. The liner (18) includes a resin absorbent material with an impermeable membrane forming an outer layer as does the inflation bladder. An exhaust assembly is attached at the trailing end of the liner (18) and is passed through a pressurized inversion apparatus into the collapsed liner (18). As the bladder reaches the distal end (17), the exhaust exits the inverting bladder and is coupled to an exhaust hose. Steam is then introduced the inversion apparatus to cure the resin and is also exhausted through the exhaust tube. After cure, steam is replaced with air to cool the liner (18) and the ends are cut to restore service through the host pipe (12).
Patent NZ-556273-A (NZ)
Title: Pyrrolopyrazoles, potent kinase inhibitors
Inventor: BOUZIDA DJAMAL
IPC: A61P35/00
Filed: 2005-12-28
Abstract: Disclosed is a compound of formula I wherein the substituents are described in the specification. Also disclosed is the use of a therapeutically acceptable amount of the compound or salt of in the manufacture of a medicament for treating a mammalian disease condition mediated by protein kinase activity including tumor growth or abnormal cell proliferation.
Patent NZ-560763-A (NZ)
Title: Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberclosis
Inventor: CHANG YUNG-FU
IPC: A01N63/00
Filed: 2006-02-16
Abstract: Provided is a method for stimulating an immune response in a ruminant comprising administering an effective amount of a composition comprising at least five immunogenic components, wherein the immunogenic components are isolated polynucleotide sequences encoding MPT antigens and wherein the MPT antigens are MPT antigens 85A, 85B, 85C, MPT 35kDa protein, and superoxide dismutase (SOD). Also provided is the corresponding composition for use in ruminants.